Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,156.00
Bid: 12,124.00
Ask: 12,128.00
Change: 0.00 (0.00%)
Spread: 4.00 (0.033%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 3-Ghana kicks off coronavirus vaccination campaign with COVAX shots

Tue, 02nd Mar 2021 15:21

* President says Ghana to inoculate 20 million people by
year-end

* COVAX vaccines scheme accelerates deliveries

* Nigeria, Angola, Congo receive COVAX vaccines on Tuesday
(Updates with vaccine delivery to Congo and Gambia)

By Christian Akorlie

ACCRA, March 2 (Reuters) - Ghana launched its coronavirus
vaccination drive on Tuesday with doses from the global COVAX
vaccine-sharing programme, which delivered shipments to other
African countries as its vaccine rollout to developing nations
accelerates.

The start of vaccinations in Ghana, and in neighbouring
Ivory Coast on Monday, along with the expected delivery of
millions of vaccines from the COVAX programme this week, will
enable more poor countries to start inoculating mostly frontline
workers and the most vulnerable, months after wealthier
countries began.

COVAX is the programme backed by the World Health
Organization and GAVI vaccine alliance to provide vaccines for
poor and middle-income countries. It said on
Tuesday it aims to deliver 237 million doses of AstraZeneca's
shot to 142 countries by the end of May.

On Tuesday, COVAX delivered 3.92 million doses of the
vaccine to Nigeria, 1.7 million doses to Democratic Republic of
Congo, 624,000 to Angola and 36,000 to Gambia. Senegal expects
324,000 doses from the scheme to arrive on Wednesday.

"This is a historic and momentous occasion for The Gambia,"
Health Minister Ahmadou Lamin Samateh said in a statement.

In Ghana, people lined up outside the regional hospital in
the capital, Accra, for a first phase of vaccinations which is
prioritising frontline health workers and others at high risk.

"I feel so good about taking the vaccine. It will protect me
from contracting the virus from patients," said Bernice
Anaglatey, 42, who works in the COVID-19 intensive care unit at
Accra's Ridge Hospital as she queued for her shot.

The West African country aims to vaccinate 20 million
people, or over 66% of its population, by the end of 2021,
according to President Nana Akufo-Addo.

Drones from U.S.-based startup Zipline delivered some of the
vaccines to health facilities, making Ghana the first in the
world to use the technology on a national scale to deliver
COVID-19 shots, the company said.

Only a handful of other African countries have started
inoculations, with doses bought bilaterally or received as
donations.

Vaccine shipments through the COVAX scheme are expected to
accelerate this week with the delivery of 11 million AstraZeneca
and Pfizer-BioNTech doses.

Health authorities are also stepping up efforts to fight
conspiracy theories around the vaccines. President Akufo-Addo
and his wife were inoculated on Monday in an effort to boost
public confidence in the vaccines. nL5N2KY0W2]

"The stories I heard about the vaccine have put fear in me,"
said Isaac Armah, a 28-year-old trader in Accra. "I'll wait for
about two months to see the effects of the vaccine on the early
recipients, then I'll make up my mind."

Coronavirus infections in Ghana have surpassed 84,000 and
more than 600 people have died, according to health ministry
data.

(Reporting by Christian Akorlie
Additional reporting by Fiston Mahamba in Goma and Pap Saine in
Banjul, Writing by Nellie Peyton and Alessandra Prentice;
Editing by Bate Felix, Emelia Sithole-Matarise, Aurora Ellis and
Nick Macfie)

More News
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.